Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.
In this study, we investigated serum epidermal growth factor (EGF) in an oncological population of head- and neck and pulmonary neoplasms and whether serum EGF could serve as a prognostic marker of survival and as a predictive marker for treatment response to platinum-based chemotherapy. A total of...
Guardado en:
Autores principales: | Margot Geens, Sofie Stappers, Heleen Konings, Benedicte Y De Winter, Pol Specenier, Jan P Van Meerbeeck, Gert A Verpooten, Steven Abrams, Annelies Janssens, Marc Peeters, Paul Van de Heyning, Olivier M Vanderveken, Kristien J Ledeganck |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/599d207c84594a2fa43102b4cb08af5c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biopsy or Biomarker? Children With Minimal Change Disease Have a Distinct Profile of Urinary Epidermal Growth Factor
por: Niels Lodeweyckx, et al.
Publicado: (2021) -
A rare case of primary mucosal melanoma involving the oropharynx
por: Anne Sophie Bonte, et al.
Publicado: (2021) -
Observing the oxidation of platinum
por: Matthijs A. van Spronsen, et al.
Publicado: (2017) -
Anticancer Platinum Drugs Update
por: Giuliano Ciarimboli
Publicado: (2021) -
Development and Pilot Use of a Questionnaire to Assess the Knowledge of Midwives and Pediatric Nurses on Maternal Use of Analgesics during Lactation
por: Ine Janssens, et al.
Publicado: (2021)